CurrentCardio coverage · page 4 of 21
European Journal of Preventive Cardiology
Latest from European Journal of Preventive Cardiology
Eur J Prev Cardiol
Association of cardiometabolic disease with subclinical cardiac remodeling in men vs. women in the Framingham Heart Study
Cross-sectional studyCardiometabolic & kidney
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
ASCVD risk stratification using apolipoprotein B and the LDL-C to total cholesterol ratio
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Eur J Prev Cardiol
Cardiovascular risk in women with metabolic dysfunction-associated steatotic liver disease across the menopausal transition
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
The impact of lipoprotein(a) on coronary atherosclerotic plaque phenotype in primary prevention
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Climate change and cardiovascular risk factors management: emerging challenges and strategies for prevention and adaptation
Research articlePrevention & lipids
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Sex-specific cardiovascular risk of lower potassium intake in patients with CKD
Cohort studyCardiometabolic & kidney
Eur J Prev Cardiol
Eur J Prev Cardiol
Prediabetes and the risk of atrial fibrillation: systematic review, meta-analysis, and dose–response meta-analysis
Meta-analysisArrhythmias & EP
Eur J Prev Cardiol
Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolaemia
Diagnostic or prognostic studyPrevention & lipids
Eur J Prev Cardiol
Life-course social mobility and cardiometabolic disease: evidence from five international cohorts
Meta-analysisCardiometabolic & kidney
Eur J Prev Cardiol
Eur J Prev Cardiol
Timing of moderate-to-vigorous physical activity and mortality risk: role of chronotype and sleep patterns
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Eur J Prev Cardiol
Dynamic surveillance of the cardiovascular risk and identification of treatment responders in type 2 diabetes using a machine learning–based model
Diagnostic or prognostic studyCardiometabolic & kidney
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Cardiovascular health across childhood and adolescence and proteomic biomarkers in late adolescence
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Machine learning-driven prioritization of lipoprotein(a) testing: model development and validation
Diagnostic or prognostic studyPrevention & lipids
Eur J Prev Cardiol
Relationship between achieved LDL-C and saphenous vein graft patency: a post hoc analysis of the NEWTON-CABG CardioLink-5 study
Secondary analysisCoronary & ACS
Eur J Prev Cardiol
Using population-wide electronic health records for timely contemporary assessment of cardiovascular disease risk prediction model performance: COVID-19 impact on the SCORE2 models
Diagnostic or prognostic studyPrevention & lipids
Eur J Prev Cardiol
Evinacumab with or without lipoprotein apheresis in homozygous familial hypercholesterolaemia
Secondary analysisPrevention & lipids
Eur J Prev Cardiol
Eur J Prev Cardiol
Eur J Prev Cardiol
Frailty as a risk-enhancing factor across the cardiovascular–kidney–metabolic framework: findings from the UK Biobank
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Combined variations in sleep, physical activity, and nutrition and the risk of major adverse cardiovascular events
Cohort studyPrevention & lipids
Eur J Prev Cardiol
Prediabetes and 20-year cardiovascular disease incidence: the ATTICA cohort study (2002–2022)
Cohort studyPrevention & lipids